Article
Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
Arthritis & rheumatology (Hoboken, N.J.) - 1 Nov 2017
Kuemmerle-Deschner J B, Verma D, Endres T, Broderick L, de Jesus A A, Hofer F, Blank N, Krause K, Rietschel C, Horneff G, Aksentijevich I, Lohse P, Goldbach-Mansky R, Hoffman H M, Benseler S M
Abstract excerpt
OBJECTIVE: Cryopyrin-associated periodic syndromes (CAPS) result from gain-of-function mutations in the NLRP3 gene, which causes excessive release of interleukin-1β (IL-1β) and systemic inflammation. While pathogenetic NLRP3 variant phenotypes are well-characterized, low-penetrance NLRP3 variants represent a significant clinical challenge. The aims of this study were to determine the clinical phenotype, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
